Synthetic Oligonucleotides: The Development of Antisense Therapeutics

Toxicologic Pathology - United States
doi 10.1177/019262339902700103
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Characterization of Stereoisomerism of Antisense Oligonucleotides.

NIPPON KAGAKU KAISHI
1995English

Mechanisms of the Inhibition of Reverse Transcription by Antisense Oligonucleotides.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Targeted Delivery of Antisense Oligonucleotides to Pancreatic Β-Cells

Science advances
Multidisciplinary
2018English

Immunogenicity for Antisense Oligonucleotides: A Risk-Based Assessment

Bioanalysis
PharmacologyAnalytical ChemistryMedical Laboratory TechnologyClinical BiochemistryMedicineToxicologyPharmaceutics
2019English

Specific Block of Androgen Receptor Activity by Antisense Oligonucleotides

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2003English

In Vivo Suppression of the Renal Na+/Pi Cotransporter by Antisense Oligonucleotides.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Perfluoroaryl Bicyclic Cell-Penetrating Peptides for Delivery of Antisense Oligonucleotides

Angewandte Chemie
2018English

HER2/neu Antisense Therapeutics in Human Breast Cancer

2002English

Inhibition of Neurogenic Precursor Proliferation by Antisense Thyroid Hormone Receptor Oligonucleotides

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy